乌梅丸加减治疗稳定性劳力性心绞痛的临床观察

中国临床药理学与治疗学 ›› 2013, Vol. 18 ›› Issue (1): 83-85.

乌梅丸加减治疗稳定性劳力性心绞痛的临床观察

谢相智, 许国磊, 吴欣芳, 陈君

中国中医科学院广安门医院南区内一科,北京 102600

收稿日期:2012-06-30 修回日期:2012-06-30 发布日期:2013-02-05
作者简介:谢相智,男,本科,主治医师,研究方向:中医治疗心血管病。 Tel: 010-60283723 E-mail: 13718079667@139.com

Clinical observation of stable angina pectoris with the treatment of Wumei Wan

XIE Xiang-zhi, XU Guo-lei, WU Xin-fang, CHEN Jun

First Department of Internal Medicine,the Southern Branch of Guang An Men Hospital of China Academy of Traditional Chinese Medicine,Beijing 102600,China

Received:2012-06-30 Revised:2012-06-30 Published:2013-02-05

摘要/Abstract

摘要： 目的: 观察乌梅丸治疗冠心病稳定性心绞痛患者的临床疗效。方法: 采用随机对照的临床试验,将78例稳定型心绞痛患者随机分为治疗组和对照组,治疗4周,通过观察患者临床症状、心电图、西雅图心绞痛量表积分来评定乌梅丸的治疗效果。结果: 两组治疗4周后,治疗组在改善患者临床症状和生活质量方面优于对照组,差异有统计学意义(P<0.05),在改善心电图方面差异无统计学意义(P>0.05)。结论: 乌梅丸能有效改善冠心病心绞痛患者的临床症状,并能提高患者的生活质量。

关键词: 乌梅丸, 稳定性, 心绞痛, 临床观察

Abstract: AIM: To observe the clinical efficacy of treatment of stable angina pectoris with Wumei Wan. METHODS: A randomized controlled clinical trial were carried out , 78 patients with stable angina pectoris were randomly divided into Wumei Wan group and control group,patients from Wumei Wan group were treated with Wumei Wan and patients from control group were treated with common treatment. The treatment was lasted for 4 weeks. Clinical efficacy was assessed through the change of clinical symptoms, ECG, Seattle Angina scale score. RESULTS: Compared with the control group,after four weeks of treatment, the improving clinical symptoms and quality of life in Wumei Wan group was better, and there was statistically significant difference (P<0.05);there was statistically significant difference in improving ECG (P>0.05). CONCLUSION: Wumei Wan can effectively improve the clinical symptoms of patients with angina pectoris and improve the patient's quality of life.

Key words: Wumei Wan, Stability, Angina pectoris, Clinical observation

中图分类号:

R541

谢相智, 许国磊, 吴欣芳, 陈君. 乌梅丸加减治疗稳定性劳力性心绞痛的临床观察[J]. 中国临床药理学与治疗学, 2013, 18(1): 83-85.

XIE Xiang-zhi, XU Guo-lei, WU Xin-fang, CHEN Jun. Clinical observation of stable angina pectoris with the treatment of Wumei Wan[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(1): 83-85.

[1]	翟宇, 杨劲. 饮食维生素K对华法林抗凝稳定性的影响[J]. 中国临床药理学与治疗学, 2020, 25(6): 709-715.
[2]	王夏芹，何非，王同，胡章乐. 中性粒细胞/淋巴细胞比率对预测不稳定心绞痛患者冠脉病变严重程度和临床风险的意义[J]. 中国临床药理学与治疗学, 2019, 24(3): 296-300.
[3]	盛洋，张田杰. 曲美他嗪对稳定型心绞痛患者血清同型半胱氨酸及谷氨酰转肽酶含量的影响[J]. 中国临床药理学与治疗学, 2018, 23(8): 922-926.
[4]	范美君，王金龄，马锴，孔秀玲. 基于三联疗法治疗幽门螺杆菌相关复发性口腔溃疡56例[J]. 中国临床药理学与治疗学, 2017, 22(9): 1050-1055.
[5]	王珏，乔青，程茂良，李万春，汪亦品，应葳. 银杏叶片对不稳定型心绞痛患者MPA、CD11b及MCP-1水平的影响[J]. 中国临床药理学与治疗学, 2017, 22(12): 1421-1425.
[6]	俞子恒，韦凡平，程震锋. 小剂量秋水仙碱对不稳定心绞痛合并高尿酸患者胸痛改善的作用[J]. 中国临床药理学与治疗学, 2016, 21(4): 455-457.
[7]	周千星，袁春菊，鄢高亮，左鹏飞，陈龙. 蛋白酶激活受体-2对动脉粥样硬化斑块发展和稳定性作用的实验研究[J]. 中国临床药理学与治疗学, 2016, 21(11): 1233-1238.
[8]	赵春梅, 王安才, 王德国. 骨髓干细胞治疗心脏疾病的临床新进展[J]. 中国临床药理学与治疗学, 2014, 19(8): 948-952.
[9]	霍永佳. 氟伐他汀对高脂血症伴冠心病患者的临床疗效评价[J]. 中国临床药理学与治疗学, 2011, 16(2): 200-203.
[10]	浦江晨, 沈丽华. 3类活血化瘀中成药对冠心病稳定型心绞痛血管内皮功能的影响[J]. 中国临床药理学与治疗学, 2010, 15(3): 331-334.
[11]	周萍. 三种头孢类药物的输液稳定性影响因素研究[J]. 中国临床药理学与治疗学, 2009, 14(7): 770-774.
[12]	史海霞, 黄继汉, 李庆海, 卞卡. 祛瘀宁心丸治疗不稳定型心绞痛的疗效及其血清C-反应蛋白的影响[J]. 中国临床药理学与治疗学, 2009, 14(5): 582-585.
[13]	陈述, 张晶, 严凤娣, 燕建峰, 袁彬, 何胜虎. 稳定型心绞痛患者血清一氧化氮、内皮素、血管内皮生长因子水平变化及丹参多酚酸盐的干预作用[J]. 中国临床药理学与治疗学, 2009, 14(10): 1160-1163.
[14]	杨娟, 何迎春, 许羚, 吕映华, 陈君超, 郑青山. 注射用红花黄色素治疗稳定型劳累性心绞痛疗效的系统评价[J]. 中国临床药理学与治疗学, 2008, 13(9): 1029-1036.
[15]	吕映华, 何迎春, 杨娟, 许羚, 刘红霞, 郑青山. 冠心病心绞痛(气虚血瘀证)症状疗效评分量表的研究[J]. 中国临床药理学与治疗学, 2008, 13(7): 786-791.